First Time Loading...

MacroGenics Inc
NASDAQ:MGNX

Watchlist Manager
MacroGenics Inc Logo
MacroGenics Inc
NASDAQ:MGNX
Watchlist
Price: 15.55 USD 5.21% Market Closed
Updated: May 2, 2024

MacroGenics Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

MacroGenics Inc
Revenue Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
MacroGenics Inc
NASDAQ:MGNX
Revenue
$58.7m
CAGR 3-Years
-18%
CAGR 5-Years
0%
CAGR 10-Years
0%
Abbvie Inc
NYSE:ABBV
Revenue
$54.3B
CAGR 3-Years
6%
CAGR 5-Years
11%
CAGR 10-Years
11%
Gilead Sciences Inc
NASDAQ:GILD
Revenue
$27.5B
CAGR 3-Years
2%
CAGR 5-Years
4%
CAGR 10-Years
7%
Amgen Inc
NASDAQ:AMGN
Revenue
$28.2B
CAGR 3-Years
4%
CAGR 5-Years
3%
CAGR 10-Years
4%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Revenue
$9.9B
CAGR 3-Years
17%
CAGR 5-Years
26%
CAGR 10-Years
23%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Revenue
$13.1B
CAGR 3-Years
16%
CAGR 5-Years
14%
CAGR 10-Years
20%

MacroGenics Inc
Revenue Breakdown

Breakdown by Geography
MacroGenics Inc

Not Available

Breakdown by Segments
MacroGenics Inc

Total Revenue: 58.7m USD
100%
Revenue From Collaborative Agreements: 29m USD
49.3%
Product: 17.9m USD
30.5%
Contract Manufacturing: 9.8m USD
16.7%
Revenue From Government Agreements: 1.6m USD
2.6%
Revenuefromroyalityagreementsmember: 431k USD
0.7%
Show More
Show Less

See Also

What is MacroGenics Inc's Revenue?
Revenue
58.7m USD

Based on the financial report for Dec 31, 2023, MacroGenics Inc's Revenue amounts to 58.7m USD.

What is MacroGenics Inc's Revenue growth rate?
Revenue CAGR 10Y
0%

Over the last year, the Revenue growth was -61%. The average annual Revenue growth rates for MacroGenics Inc have been -18% over the past three years .